IRadimed Corporation IRMD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 89.34M | 86.34M | 86.28M | 83.81M | 80.51M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 89.34M | 86.34M | 86.28M | 83.81M | 80.51M |
| Cost of Revenue | 21.88M | 20.84M | 19.99M | 19.49M | 18.46M |
| Gross Profit | 67.46M | 65.50M | 66.29M | 64.32M | 62.05M |
| SG&A Expenses | 35.34M | 34.88M | 35.06M | 35.23M | 34.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 60.48M | 58.78M | 58.33M | 57.67M | 55.66M |
| Operating Income | 28.86M | 27.55M | 27.95M | 26.15M | 24.85M |
| Income Before Tax | 31.12M | 29.74M | 30.18M | 28.36M | 26.91M |
| Income Tax Expenses | 7.13M | 6.69M | 6.57M | 5.88M | 5.73M |
| Earnings from Continuing Operations | 23.98 | 23.05 | 23.61 | 22.48 | 21.18 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.98M | 23.05M | 23.61M | 22.48M | 21.18M |
| EBIT | 28.86M | 27.55M | 27.95M | 26.15M | 24.85M |
| EBITDA | 30.52M | 29.18M | 29.38M | 27.31M | 25.83M |
| EPS Basic | 1.88 | 1.81 | 1.85 | 1.77 | 1.67 |
| Normalized Basic EPS | 1.51 | 1.45 | 1.47 | 1.38 | 1.32 |
| EPS Diluted | 1.87 | 1.79 | 1.83 | 1.75 | 1.65 |
| Normalized Diluted EPS | 1.50 | 1.43 | 1.46 | 1.37 | 1.31 |
| Average Basic Shares Outstanding | 51.09M | 51.03M | 50.96M | 50.89M | 50.83M |
| Average Diluted Shares Outstanding | 51.49M | 51.48M | 51.44M | 51.40M | 51.33M |
| Dividend Per Share | 0.80 | 0.77 | 0.74 | 0.71 | 0.68 |
| Payout Ratio | 67.65% | 68.67% | 65.37% | 66.91% | 39.59% |